Quarterly ResultApr 28, 2026, 05:12 PM
ASH Q2 Sales +1% to $482M; Adj EBITDA -9%; Updates FY Outlook
AI Summary
Ashland Inc. reported preliminary second-quarter fiscal 2026 results with sales up 1% to $482 million, but Adjusted EBITDA decreased 9% to $98 million due to operational challenges at Calvert City and Hopewell, and weather disruptions. Net income fell to $16 million. The company updated its full-year fiscal 2026 sales guidance to $1,835-$1,870 million and Adjusted EBITDA guidance to $385-$400 million, primarily reflecting slower productivity at Hopewell.
Key Highlights
- Q2 Sales increased 1% to $482 million from the prior-year quarter.
- Q2 Net income was $16 million, or $0.34 per diluted share, down from $31 million.
- Q2 Adjusted EBITDA decreased 9% to $98 million, with a 20% margin.
- Q2 Cash flows provided by operating activities were $50 million, up from $9 million.
- Updated full-year fiscal 2026 sales guidance to $1,835-$1,870 million.
- Updated full-year fiscal 2026 Adjusted EBITDA guidance to $385-$400 million.
- Life Sciences segment sales were $172 million (flat YoY); Personal Care sales rose 3% to $150 million.
Price Impact
More from ASH